Neuropsychiatric symptom clusters across the cognitive impairment spectrum in advanced age: a data-driven analysis integrating AD biomarker and clinical profiling
Abstract
Neuropsychiatric symptoms (NPS) are among the most common manifestations of cognitive impairment, yet their heterogeneity complicates understanding of how they relate to Alzheimer’s disease (AD) pathology. While individual NPS have been linked to AD biomarker burden, the interplay between co-occurring neuropsychiatric profiles and AD biomarkers in shaping cognitive and functional outcomes remains insufficiently understood. This study used data-driven clustering to identify NPS clusters in 300 individuals (156 mild cognitive impairment, 112 AD dementia, 32 non-AD dementia) using the 12 domains of Neuropsychiatric Inventory. K-means clustering identified three clusters: Minimal/No NPS (55.7%), Apathy-Behavioral Dysregulation (17.7%), and Depression-Anxiety/Affective (26.7%). Clusters differed significantly in age, sex, education, cognitive status, and diagnostic composition (all p < .05). The Apathy-Behavioral cluster showed advanced cognitive impairment and AD/non-AD dementia predominance, whereas the Depression-Anxiety cluster showed preserved cognition, female predominance, and highest vascular risk factor prevalence. Measured AD pathology (plasma pTau217, CSF amyloid and tau) did not differ across clusters, whereas APOE ε4 carriership was higher in the two symptomatic clusters (both 44.4% vs. 26.0%; p = .032), an association that did not persist after multivariable adjustment. Hierarchical regression revealed five of eight biomarker-outcome associations were largely independent of NPS clusters (change < 10%), with exceptions involving functional outcome: pTau217 (11.4%), tau (17.7%), and APOE ε4 (29.6%). Findings are consistent with a parallel-pathway hypothesis: measured AD pathology and NPS clusters showed largely independent associations with cognition, with only partial overlap in their associations with functional status.
Related
- Longitudinal associations between neuropsychiatric symptoms, structural and perfusion MRI changes in older adults with Mild Cognitive Impairment
- Overall and domain-specific neuropsychiatric symptoms in relation to caregiver burden among family caregivers of individuals with cognitive impairment
- Memory Self-Awareness Phenotypes are Associated with Alzheimers Disease Biomarker Burden and Clinical Progression in Amnestic Mild Cognitive Impairment
- Plasma Neurofilament Light Chain as a Complementary Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
- CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults
BibTeX
@article{chatzikostopoulos2026neuropsychiatric,
title = {{Neuropsychiatric symptom clusters across the cognitive impairment spectrum in advanced age: a data-driven analysis integrating AD biomarker and clinical profiling}},
author = {Athanasios Chatzikostopoulos and Despina Moraitou and Konstantinos Pateras and Georgia Manafi and Anthoula Tsolaki and Georgia Papantoniou and Ioanna-Giannoula Katsouri and Maria Sofologi and Glykeria Tsentidou and Efstathios Papadopoulos and Magda Tsolaki},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-76646-y},
url = {https://www.nature.com/articles/s41598-026-76646-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Neuropsychiatric symptom clusters across the cognitive impairment spectrum in advanced age: a data-driven analysis integrating AD biomarker and clinical profiling
AU - Athanasios Chatzikostopoulos
AU - Despina Moraitou
AU - Konstantinos Pateras
AU - Georgia Manafi
AU - Anthoula Tsolaki
AU - Georgia Papantoniou
AU - Ioanna-Giannoula Katsouri
AU - Maria Sofologi
AU - Glykeria Tsentidou
AU - Efstathios Papadopoulos
AU - Magda Tsolaki
PY - 2026
DA - 2026/10/22
JO - Scientific Reports
DO - 10.1038/s41598-026-76646-y
UR - https://www.nature.com/articles/s41598-026-76646-y
AB - Neuropsychiatric symptoms (NPS) are among the most common manifestations of cognitive impairment, yet their heterogeneity complicates understanding of how they relate to Alzheimer’s disease (AD) pathology. While individual NPS have been linked to AD biomarker burden, the interplay between co-occurring neuropsychiatric profiles and AD biomarkers in shaping cognitive and functional outcomes remains insufficiently understood. This study used data-driven clustering to identify NPS clusters in 300 individuals (156 mild cognitive impairment, 112 AD dementia, 32 non-AD dementia) using the 12 domains of Neuropsychiatric Inventory. K-means clustering identified three clusters: Minimal/No NPS (55.7%), Apathy-Behavioral Dysregulation (17.7%), and Depression-Anxiety/Affective (26.7%). Clusters differed significantly in age, sex, education, cognitive status, and diagnostic composition (all p < .05). The Apathy-Behavioral cluster showed advanced cognitive impairment and AD/non-AD dementia predominance, whereas the Depression-Anxiety cluster showed preserved cognition, female predominance, and highest vascular risk factor prevalence. Measured AD pathology (plasma pTau217, CSF amyloid and tau) did not differ across clusters, whereas APOE ε4 carriership was higher in the two symptomatic clusters (both 44.4% vs. 26.0%; p = .032), an association that did not persist after multivariable adjustment. Hierarchical regression revealed five of eight biomarker-outcome associations were largely independent of NPS clusters (change < 10%), with exceptions involving functional outcome: pTau217 (11.4%), tau (17.7%), and APOE ε4 (29.6%). Findings are consistent with a parallel-pathway hypothesis: measured AD pathology and NPS clusters showed largely independent associations with cognition, with only partial overlap in their associations with functional status.
SN - 2045-2322
ER -